-
Je něco špatně v tomto záznamu ?
Self-Assembled Fluorinated Nanoparticles as Sensitive and Biocompatible Theranostic Platforms for 19F MRI
D. Havlicek, VM. Panakkal, L. Voska, O. Sedlacek, D. Jirak
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
LX22NPO5104
National Institute for Research of Metabolic and Cardiovascular Diseases
22-03102S
Grantová Agentura České Republiky
IN00023001
Ministerstvo Zdravotnictví České Republiky
NU22-08-00286
Ministerstvo Zdravotnictví České Republiky
PubMed
38217510
DOI
10.1002/mabi.202300510
Knihovny.cz E-zdroje
- MeSH
- biokompatibilní materiály chemie MeSH
- fluor chemie MeSH
- fluorokarbony chemie MeSH
- halogenace MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- micely MeSH
- myši MeSH
- nanočástice * chemie terapeutické užití MeSH
- teranostická nanomedicína * MeSH
- zobrazování fluorovou magnetickou rezonancí * metody MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Theranostics is a novel paradigm integrating therapy and diagnostics, thereby providing new prospects for overcoming the limitations of traditional treatments. In this context, perfluorocarbons (PFCs) are the most widely used tracers in preclinical fluorine-19 magnetic resonance (19F MR), primarily for their high fluorine content. However, PFCs are extremely hydrophobic, and their solutions often display reduced biocompatibility, relative instability, and subpar 19F MR relaxation times. This study aims to explore the potential of micellar 19F MR imaging (MRI) tracers, synthesized by polymerization-induced self-assembly (PISA), as alternative theranostic agents for simultaneous imaging and release of the non-steroidal antileprotic drug clofazimine. In vitro, under physiological conditions, these micelles demonstrate sustained drug release. In vivo, throughout the drug release process, they provide a highly specific and sensitive 19F MRI signal. Even after extended exposure, these fluoropolymer tracers show biocompatibility, as confirmed by the histological analysis. Moreover, the characteristics of these polymers can be broadly adjusted by design to meet the wide range of criteria for preclinical and clinical settings. Therefore, micellar 19F MRI tracers display physicochemical properties suitable for in vivo imaging, such as relaxation times and non-toxicity, and high performance as drug carriers, highlighting their potential as both diagnostic and therapeutic tools.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013800
- 003
- CZ-PrNML
- 005
- 20240905133840.0
- 007
- ta
- 008
- 240725s2024 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mabi.202300510 $2 doi
- 035 __
- $a (PubMed)38217510
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Havlicek, Dominik $u Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, Prague, 140 20, Czech Republic $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Kateřinská 1660/32, Prague, 121 08, Czech Republic $1 https://orcid.org/0000000223282181
- 245 10
- $a Self-Assembled Fluorinated Nanoparticles as Sensitive and Biocompatible Theranostic Platforms for 19F MRI / $c D. Havlicek, VM. Panakkal, L. Voska, O. Sedlacek, D. Jirak
- 520 9_
- $a Theranostics is a novel paradigm integrating therapy and diagnostics, thereby providing new prospects for overcoming the limitations of traditional treatments. In this context, perfluorocarbons (PFCs) are the most widely used tracers in preclinical fluorine-19 magnetic resonance (19F MR), primarily for their high fluorine content. However, PFCs are extremely hydrophobic, and their solutions often display reduced biocompatibility, relative instability, and subpar 19F MR relaxation times. This study aims to explore the potential of micellar 19F MR imaging (MRI) tracers, synthesized by polymerization-induced self-assembly (PISA), as alternative theranostic agents for simultaneous imaging and release of the non-steroidal antileprotic drug clofazimine. In vitro, under physiological conditions, these micelles demonstrate sustained drug release. In vivo, throughout the drug release process, they provide a highly specific and sensitive 19F MRI signal. Even after extended exposure, these fluoropolymer tracers show biocompatibility, as confirmed by the histological analysis. Moreover, the characteristics of these polymers can be broadly adjusted by design to meet the wide range of criteria for preclinical and clinical settings. Therefore, micellar 19F MRI tracers display physicochemical properties suitable for in vivo imaging, such as relaxation times and non-toxicity, and high performance as drug carriers, highlighting their potential as both diagnostic and therapeutic tools.
- 650 12
- $a teranostická nanomedicína $7 D000068936
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a zobrazování fluorovou magnetickou rezonancí $x metody $7 D066235
- 650 12
- $a nanočástice $x chemie $x terapeutické užití $7 D053758
- 650 _2
- $a biokompatibilní materiály $x chemie $7 D001672
- 650 _2
- $a micely $7 D008823
- 650 _2
- $a fluorokarbony $x chemie $7 D005466
- 650 _2
- $a fluor $x chemie $7 D005461
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a halogenace $7 D054879
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Panakkal, Vyshakh M $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Hlavova 8, Prague, 128 00, Czech Republic
- 700 1_
- $a Voska, Ludek $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, Prague, 140 20, Czech Republic
- 700 1_
- $a Sedlacek, Ondrej $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Hlavova 8, Prague, 128 00, Czech Republic $1 https://orcid.org/0000000157312687 $7 uk20211109693
- 700 1_
- $a Jirak, Daniel $u Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, Prague, 140 20, Czech Republic $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Kateřinská 1660/32, Prague, 121 08, Czech Republic $u Faculty of Health Studies, Technical University of Liberec, 1402/2 Studentská, Liberec, 46117, Czech Republic $1 https://orcid.org/0000000168343462 $7 xx0172472
- 773 0_
- $w MED00006593 $t Macromolecular bioscience $x 1616-5195 $g Roč. 24, č. 6 (2024), s. e2300510
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38217510 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133834 $b ABA008
- 999 __
- $a ok $b bmc $g 2143546 $s 1225666
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 24 $c 6 $d e2300510 $e 20240118 $i 1616-5195 $m Macromolecular bioscience $n Macromol Biosci $x MED00006593
- GRA __
- $a LX22NPO5104 $p National Institute for Research of Metabolic and Cardiovascular Diseases
- GRA __
- $a 22-03102S $p Grantová Agentura České Republiky
- GRA __
- $a IN00023001 $p Ministerstvo Zdravotnictví České Republiky
- GRA __
- $a NU22-08-00286 $p Ministerstvo Zdravotnictví České Republiky
- LZP __
- $a Pubmed-20240725